Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

US And Canada

Lemonade demonstrates $319m flotation
SoftBank, XL Catlin, Allianz and Alphabet-backed casualty and property isnurance provider Lemonade priced the initial public offering above its range.
Annexon adds $100m
The round pushed the overall funding for the Novartis-backed autoimmune and neurodegenerative disorder drug developer past $250m.
Google points North to acquisition
Google paid a reported $180m for Amazon and Intel-backed North Wearables, the augmented reality glasses developer having sought a buyer since spring.
B Capital captures $820m for second fund
The venture firm, which is partners with Boston Consulting Group, said it now has in excess of $1.4bn of assets under management.
Bolt latches onto series C financing
Novo, Pfizer and Nan Fung helped provide $93.5m for the cancer treatment developer as it advances its lead product candidate towards the clinic.
Away packs up bridge financing
Comcast Ventures-backed smart luggage brand Away has reportedly secured $30m to $40m in bridge financing as it faces a downturn in business due to the coronavirus.
Mynd houses series C funding
Wells Fargo led a $41.5m round for the tech-equipped property manager that included existing backers Canaan Partners, Lightspeed Venture Partners and Jackson Square Ventures.
Shift gears up for reverse merger
The Lithia Motors, BMW and Alliance Ventures-backed automotive e-commerce marketplace is set to go public through a reverse merger with Insurance Acquisition.

Other News

Mirror reflects on $500m acquisition
At-home fitness company Mirror is set to be acquired by Lululemon for $500m, after the corporate contributed to its series B round in November.
Coty cuts off $200m for KKW investment
The beauty and cosmetics group is acquiring a 20% stake in Kim Kardashian West's beauty brand at a $1bn valuation in connection with a partnership agreement.
Goldfinch Bio holds on to $100m
Existing backer Gilead Sciences returned for a series B round that boosted the kidney disease therapy developer's total funding to $160m.
Discord discovers another $100m
Index Ventures participated in a round that valued the WarnerMedia and Tencent-backed communication platform developer at $3.5bn.
Enko Chem reaps $45m series B
Rabobank was among the investors as the crop protection technology developer publicly launched having raised a total of $66m since inception.
Empower to purchase Personal Capital for $825m
BBVA, USAA and Power Financial are set to exit wealth management technology provider Personal Capital in an $825m transaction.

Editor's Picks

Lemonade demonstrates $319m flotation
SoftBank, XL Catlin, Allianz and Alphabet-backed casualty and property isnurance provider Lemonade priced the initial public offering above its range.
Amazon assembles $2bn Climate Pledge Fund
Areas to be targeted by Climate Pledge Fund will include transport, logistics, manufacturing, materials, renewable energy, food and agriculture technology.
Forma Therapeutics finishes IPO at $319m
Forma Therapeutics, whose investors include Eli Lilly and Novartis, has closed its IPO after seeing its shares double in price.
Forma forces its way to $278m IPO
The Novartis and Eli Lilly-backed cancer and haematologic disease drug developer will go public today having expanded the size of its offering.
test reg

Login